Motor Neurone Disease Trial, Recruiting NCT07226284 Sponsor: University of Minnesota Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT07226284
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease (a common form of Parkinson's not caused by another condition).
  • People whose Parkinson's medication has remained the same for the past month and is expected to stay the same for the next 3 months.
  • People who are able to walk more than 50 metres without using a walking aid such as a cane, walker, or crutches.

For the control group (people without Parkinson's disease):

  • People whose age (within 3 years) and sex are similar to those of participants in the Parkinson's group.
  • People who are able to walk more than 50 metres without using a walking aid.

Who may not be able to join:

  • People who are unable to demonstrate the capacity to give informed consent, as assessed using specific standardised tools.
  • People who have a history of a significant brain or nervous system condition (other than Parkinson's disease, for those in the Parkinson's group).
  • People who have a history of stroke, traumatic brain injury, a brain aneurysm, bleeding in the brain, a brain tumour, or an atypical form of Parkinson's-like disorder.
  • People with a severe bone, joint, or muscle condition that significantly affects the way they walk.
  • People who are pregnant or may be pregnant.
  • People who do not have sufficient understanding of the English language.
  • People with a history of substance abuse within the past 2 years.

Additional criteria for the part of the trial involving nerve stimulation on the neck (nVNS):

  • People who experience pain, unusual skin sensations, or nerve pain at the side of the neck where the stimulation device would be applied.
  • People who have a wound, rash, infection, swelling, skin condition, surgical scar, or abnormal anatomy at the stimulation site, or who have had previous neck surgery such as carotid artery surgery.
  • People with known or suspected serious heart or artery conditions, including severe narrowing of the carotid arteries, heart failure, severe coronary artery disease, or a previous heart attack.
  • People who have had an abnormal heart tracing (ECG) within the past year, including certain irregular heart rhythms or conduction problems (confirm with trial site).
  • People with a recent history of uncontrolled high blood pressure, an unusually slow or fast heart rate, or a known history of a sudden drop in blood pressure when standing up.
  • People who have previously had a surgical procedure to cut the vagus nerve on one or both sides.
  • People who have metal implants or medical devices in or near the neck or head, such as a deep brain stimulator, pacemaker, hearing implant, metal spinal hardware, implanted defibrillator, aneurysm clips, neurostimulator, valve replacements, stents, or metallic prostheses near the stimulation site.
  • People who have a history of fainting episodes or seizures within the past 2 years.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 612-625-8938

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 February 2026
Est. completion
1 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in delta-F

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov